This meeting took place in 2016


Here are the related meetings in 2017:
HIV Vaccines (C9)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

HIV Vaccines (X8)


Organizer(s) David C. Montefiori and Mario Roederer
March 20—24, 2016
Resort at Squaw Creek • Olympic Valley, California USA
Discounted Abstract Deadline: Nov 19, 2015
Abstract Deadline: Dec 17, 2015
Scholarship Deadline: Nov 19, 2015
Discounted Registration Deadline: Jan 21, 2016

Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation.


Summary of Meeting:
The development of a safe and effective HIV vaccine remains a major global health priority and a complex problem to solve. Current efforts emphasize an ability to elicit systemic and mucosal antibody responses capable of preventing the acquisition of infection. Evidence from multiple passive transfer experiments in non-human primates, as well as from studies of immunologic correlates of modest efficacy in the RV144 Thai trial, support the notion that both neutralizing and non-neutralizing antibodies have potential to prevent infection. Major advances have been made in understanding the epitopes, structures and evolutionary pathways of broadly neutralizing antibodies, leading to new avenues to pursue for vaccine design. The extraordinary breadth and potency of some recently discovered neutralizing antibodies has generated additional interest in potential therapeutic applications, including cure strategies. There has also been a steady increase in knowledge of other types of antiviral antibodies and their effector functions that may be important for vaccines. This meeting aims to cover a range of topics including: 1) Initial virus transmission events for vaccine intervention, 2) Non-neutralizing antibody correlates of sterilizing immunity; 3) Epitopes, structures and ontogeny of broadly neutralizing antibodies; 4) Novel vaccine concepts for broadly neutralizing antibody induction; and 5) Immunotherapy. Emphasis will be placed on recent unpublished findings in key areas that hold the greatest promise for rapid progress toward an effective vaccine.

View Meeting Program

Scholarships/Awards

Keystone Symposia Future of Science Fund Scholarship Recipients

Christina Guzzo
NIAID, National Institutes of Health, USA

National Institute of Allergy and Infectious Diseases (NIAID) Scholarship Recipients

Raymond A. Alvarez
, USA

Anne-Marie Andersson
Faculty of Health and Medical Sciences, University of Copenhagen, Denmark

Michael John Hogan
University of Pennsylvania, USA

Edward Kreider
University of Pennsylvania, USA

Laura E. McCoy
The Scripps Research Institute, USA

Daniela Mónaco
Emory University, USA

Tom Partridge
University of Oxford, UK

Jonathan Richard
Centre de Recherche du CHUM, Canada

Anna Schorcht
Academic Medical Center Amsterdam, Netherlands

Philippe Selhorst
University of Cape Town, South Africa

Cassandra Simonich
Fred Hutchinson Cancer Research Center, USA

Saintedym Wills
Duke University, USA

Keystone Symposia Global Health Travel Award Recipients, funded by the Bill & Melinda Gates Foundation
Funded by Keystone Symposia Global Health Travel Award Recipients, funded by the Bill & Melinda Gates Foundation

Abiodun Adebimpe Adegoke
Ladoke Akintola University of Technology, Nigeria

Yonas Ashebir Ahmed
ALERT/AHRI, Ethiopia

Seema Parmanand Ajbani
National Institute for Research in Reproductive Health, India

Omolara Olujimi Baiyegunhi
University of KwaZulu-Natal, South Africa

John Martin Buwembo
Uganda Virus Research Institute, Uganda

Dalziza Victalina de Almeida
Fiocruz, Brazil

One Bridget Dintwe
Cape Town HVTN Immunology Laboratory, South Africa

Adaobi Jennifer Iheanyi
University of Port Harcourt, Nigeria

Marion Wangui Kiguoya
Kenya AIDS Control Project, Kenya

Muzamil Ashraf Makhdoomi
All India Institute of Medical Sciences, India

Kewreshini Kasturi Naidoo
University of KwaZulu Natal, South Africa

Hua Wang
Tsinghua University, China

Constantinos Kurt Wibmer
National Institute for Communicable Diseases, South Africa